CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cotterchio, M.
Right arrow Articles by Steingart, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cotterchio, M.
Right arrow Articles by Steingart, A.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 1213-1217, November 2001
© 2001 American Association for Cancer Research

Short Communication

Nonsteroidal Anti-inflammatory Drug Use and Breast Cancer Risk1

Michelle Cotterchio2, Nancy Kreiger, Margaret Sloan and Allan Steingart

Division of Preventive Oncology, Research Unit, Cancer Care Ontario [M. C., N. K., M. S.], and Departments of Public Health Sciences [M. C., N. K.] and Psychiatry [A. S.], University of Toronto, Toronto, Ontario, M5G 2L7 Canada

Findings from previous epidemiological studies are inconclusive, though they suggest nonsteroidal anti-inflammatory drug (NSAID) use is associated with a reduction in breast cancer risk. In addition, animal studies report that NSAIDs inhibit mammary tumor development. The association between NSAID use and breast cancer risk was evaluated using a case-control study design. Cases were a random sample of women diagnosed with a first primary cancer of the breast, aged 25–74 years, identified through the Ontario Cancer Registry, and diagnosed between July 1996 and September 1998. Controls were an age-matched random sample of the female population of Ontario. Cases (n = 3133) and controls (n = 3062) completed a mailed questionnaire with information on their past use of NSAID and other medications, as well as many risk factors thought to be associated with breast cancer. Multivariate logistic regression analysis was used to obtain adjusted odds ratio (OR) estimates. Use of any NSAID medication (daily use for >=2 months) was found to be associated with a significant 24% reduction in breast cancer risk (OR = 0.76; 95% confidence interval: 0.66, 0.88). The reduced risk was strongest for use lasting >8 years, compared with nonusers (OR = 0.68; 95% confidence interval: 0.54, 0.86). No marked trends were observed for time since first use or last use or age at first use. Our results suggest a reduction in breast cancer risk associated with any regular NSAID use. NSAID use is a modifiable factor, and any protective effect attributed to its use could be of great public health importance.




This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. B. Terry, D. S.M. Buist, A. Trentham-Dietz, T. M. James-Todd, and Y. Liao
Nonsteroidal Anti-inflammatory Drugs and Change in Mammographic Density: A Cohort Study Using Pharmacy Records on Over 29,000 Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1088 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
V. A. Kirsh, N. Kreiger, M. Cotterchio, M. Sloan, and B. Theis
Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup Findings
Am. J. Epidemiol., September 15, 2007; 166(6): 709 - 716.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
Y. Zhang, P. F. Coogan, J. R. Palmer, B. L. Strom, and L. Rosenberg
Use of Nonsteroidal Antiinflammatory Drugs and Risk of Breast Cancer: The Case-Control Surveillance Study Revisited
Am. J. Epidemiol., July 15, 2005; 162(2): 165 - 170.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. F. Marshall, L. Bernstein, H. Anton-Culver, D. Deapen, P. L. Horn-Ross, H. Mohrenweiser, D. Peel, R. Pinder, D. M. Purdie, P. Reynolds, et al.
Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor Status
J Natl Cancer Inst, June 1, 2005; 97(11): 805 - 812.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Zhou, T. Suzuki, A. Kovacic, R. Saito, Y. Miki, T. Ishida, T. Moriya, E. R. Simpson, H. Sasano, and C. D. Clyne
Interactions between Prostaglandin E2, Liver Receptor Homologue-1, and Aromatase in Breast Cancer
Cancer Res., January 15, 2005; 65(2): 657 - 663.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. J. Jacobs, M. J. Thun, C. J. Connell, C. Rodriguez, S. J. Henley, H. S. Feigelson, A. V. Patel, W. D. Flanders, and E. E. Calle
Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Breast Cancer Incidence in a Large U.S. Cohort
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 261 - 264.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. B. Terry, M. D. Gammon, F. F. Zhang, H. Tawfik, S. L. Teitelbaum, J. A. Britton, K. Subbaramaiah, A. J. Dannenberg, and A. I. Neugut
Association of Frequency and Duration of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk
JAMA, May 26, 2004; 291(20): 2433 - 2440.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Ulrich, J. Bigler, R. Sparks, J. Whitton, J. G. Sibert, E. L. Goode, Y. Yasui, and J. D. Potter
Polymorphisms in PTGS1 (=COX-1) and Risk of Colorectal Polyps
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 889 - 893.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
A. Steingart, M. Cotterchio, N. Kreiger, and M. Sloan
Antidepressant medication use and breast cancer risk: a case-control study
Int. J. Epidemiol., December 1, 2003; 32(6): 961 - 966.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Cotterchio, N. Kreiger, B. Theis, M. Sloan, and S. Bahl
Hormonal Factors and the Risk of Breast Cancer According to Estrogen- and Progesterone-Receptor Subgroup
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1053 - 1060.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. E. Harris, R. T. Chlebowski, R. D. Jackson, D. J. Frid, J. L. Ascenseo, G. Anderson, A. Loar, R. J. Rodabough, E. White, and A. McTiernan
Breast Cancer and Nonsteroidal Anti-Inflammatory Drugs: Prospective Results from the Women's Health Initiative
Cancer Res., September 15, 2003; 63(18): 6096 - 6101.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. Mokbel, G. Singh-Ranger, K. Kirkpatrick, and M. Cotterchio
Correspondence re: Cotterchio et al., Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk. Cancer Epidemiol. Biomark. Prev., 10: 1213-1217, 2001: Letter
Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 674 - 674.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. J. Baek, L. C. Wilson, C.-H. Lee, and T. E. Eling
Dual Function of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Inhibition of Cyclooxygenase and Induction of NSAID-Activated Gene
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1126 - 1131.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2001 by the American Association for Cancer Research.